Intersect ENT Announces Appointment of Chief Financial Officer Jeryl Hilleman  
6/4/2014 7:20:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Intersect ENT, Inc., a commercial stage drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions, today announced the appointment of Jeryl Hilleman as chief financial officer. Ms. Hilleman brings significant financial and executive experience to Intersect ENT, having served as chief financial officer for several publicly traded life science and clean technology companies.

Help employers find you! Check out all the jobs and post your resume.